Kurve Technology, Inc., a company out of Bothell, WA, has been granted a US patent for its nasal drug delivery system called Controlled Particle Dispersion®, that “delivers aerosolized particles to the nose and imparts a turbulent flow to the particles often in the form of one or more vortices.” The company believes that its devices (ViaNase and ViaNase ID Electronic Atomizers) have more predictable and controlled intranasal drug delivery than a typical nasal spray bottle. In addition to drugs designed for treatment of intra-nasal problems, the company touts its controlled particle dispersion technology for systemic delivery of meds, nose-to-brain delivery and intranasal vaccine administration.
To learn more about company’s vortical flow technology, go to company’s website.
Press release (.pdf)…
US Patent: Particle dispersion device for nasal delivery
Frost&Sullivan’s Movers & Shakers Interview with Marc Giroux, Chairman and CEO, Kurve Technology …